InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Khan Samina. Director active across 1 company, notably Reata Pharmaceuticals INC. Cumulatively, 4 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €332k. History available since 3 January 2023. The latest transaction was filed on 15 May 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Khan Samina is a declarant linked to Reata Pharmaceuticals INC, where the listed role is SVP, Chief Medical Officer. The record shows 4 filings, and across the 4 sampled filings the transactions are sales, with total sell volume of EUR 331893 between 2023-01-04 and 2023-05-17.